Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) Peptid
PARK2
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN7236241
Kurzübersicht für Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) Peptid (ABIN7236241)
Target
Parkin (PARK2)
(Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Verwendungszweck
- E3 Ubiquitin-Protein Ligase Parkin, Parkin RBR E3 ubiquitin-protein ligase, Parkinson Juvenile Disease Protein 2, PARK2, PRKN
-
Sequenz
- Peptide (C)KELHHFRILG EEQYTR, correspond ing to amino acid residues 298 - 313 of mouse Parkin (Accession Q9WVS6).
-
Produktmerkmale
- A Blocking peptide for Anti-Parkin Antibody (ABIN7237754).
-
Reinheit
- >70 %
-
-
-
-
Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
-
Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- 100 μL double distilled water (DDW).
-
Konzentration
- 0.4 mg/mL
-
Lagerung
- RT,-20 °C
-
Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
-
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
Target
-
Sie sind hier:
